0001062993-23-018442.txt : 20230925 0001062993-23-018442.hdr.sgml : 20230925 20230925164641 ACCESSION NUMBER: 0001062993-23-018442 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20230922 FILED AS OF DATE: 20230925 DATE AS OF CHANGE: 20230925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoPrecise Antibodies Ltd. CENTRAL INDEX KEY: 0001715925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39530 FILM NUMBER: 231276310 BUSINESS ADDRESS: STREET 1: 880 - 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C3B6 BUSINESS PHONE: 6048060626 MAIL ADDRESS: STREET 1: 880 - 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C3B6 6-K 1 form6k.htm FORM 6-K ImmunoPrecise Antibodies Ltd.: Form 6-K - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2023.

Commission File Number: 001-39530



ImmunoPrecise Antibodies Ltd.
(Exact Name of Registrant as Specified in Charter)

3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  □  Form 40-F ⊠

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  IMMUNOPRECISE ANTIBODIES LTD.
     
Date:   September 25, 2023 By: /s/ Brad McConn
  Name: Brad McConn
  Title: Chief Financial Officer

EXHIBIT INDEX

99.1 Notice of the meeting and record date dated September 22, 2023

EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 ImmunoPrecise Antibodies Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com
 

Date: September 22, 2023 3204-4464 Markham St., Victoria,
British Columbia, V8Z 7X8, Canada

To: Alberta Securities Commission

British Columbia Securities Commission
Financial and Consumer Affairs Authority of Saskatchewan
Manitoba Securities Commission
Ontario Securities Commission
Financial and Consumer Services Commission of New Brunswick
Nova Scotia Securities Commission
The Office of the Superintendent Securities, Consumer, Corporate and Insurance Services Division,
Office of the Attorney General of Prince Edward Island
Office of the Superintendent of Securities, Service Newfoundland & Labrador

Subject: IMMUNOPRECISE ANTIBODIES LTD.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type : Annual General Meeting
Record Date for Notice of Meeting : October 03, 2023
Record Date for Voting (if applicable) : October 03, 2023
Beneficial Ownership Determination Date : October 03, 2023
Meeting Date : November 09, 2023
Meeting Location (if available) : Virtual Meeting
Issuer sending proxy related materials directly to NOBO: No
Issuer paying for delivery to OBO: No
 
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders No
NAA for Registered Holders No

Voting Security Details:

Description CUSIP Number ISIN
COMMON 45257F200 CA45257F2008

 

Sincerely,

IMMUNOPRECISE ANTIBODIES LTD.

 GRAPHIC 3 exhibit99-1x001.jpg GRAPHIC begin 644 exhibit99-1x001.jpg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